Treatment of pre-eclampsia using targeted apheresis

• 收藏
• 分享

专利权人:

Henry John Smith

发明人:

Henry John Smith,James Roger Smith

申请号：

US13374814

公开号：

US20120215150A1

申请日:

2012.01.17

申请国别(地区):

US

年份:

2012

代理人:

摘要：

This invention uses “targeted apheresis” to treat pregnant women who are at risk of developing eclampsia. “Targeted Apheresis” is a process whereby certain growth factor receptors (sFlt-1) circulating in the blood of a pregnant woman at risk of developing pre-eclampsia are selectively removed by passing the blood through a cartridge containing immobilized anti-sFlt-1 aptamers. The circulating sFlt-1 is bound out by the immobilized anti-sFlt-1 aptamers and the cleaned blood is returned to the patient. Removal of circulating sFlt-1 will diminish the risk of developing eclampsia during pregnancy.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/